Transgene Excision Has No Impact on In Vivo Integration of Human iPS Derived Neural Precursors
The derivation of induced human pluripotent stem cells (hiPS) has generated significant enthusiasm particularly for the prospects of cell-based therapy. But there are concerns about the suitability of iPS cells for in vivo applications due in part to the introduction of potentially oncogenic transcr...
Main Authors: | Major, Tamara, Menon, Jayanthi, Auyeung, Gordon, Soldner, Frank, Hockemeyer, Dirk, Jaenisch, Rudolf, Tabar, Viviane |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | en_US |
Published: |
Public Library of Science
2012
|
Online Access: | http://hdl.handle.net/1721.1/69089 |
Similar Items
-
Genetic engineering of human ES and iPS cells using TALE nucleases
by: Hockemeyer, Dirk, et al.
Published: (2012) -
Functional analysis of CX3CR1 in human induced pluripotent stem (iPS) cell‐derived microglia‐like cells
by: Murai, Nobuhito, et al.
Published: (2021) -
Induced Pluripotent Stem Cells Meet Genome Editing
by: Hockemeyer, Dirk, et al.
Published: (2018) -
Immortalized striatal precursor neurons from Huntington’s disease patient-derived iPS cells as a platform for target identification and screening for experimental therapeutics
by: Akimov, Sergey S, et al.
Published: (2021) -
Gender differences in the bile acid profiles of APP/PS1 transgenic AD mice
by: Wu, Junfang, et al.
Published: (2020)